Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-11-25

Clinical Trial Update: Behavioral Relaxation Approaches for Insomnia in Lung Cancer Patients [NA]

View source ↗

Summary

The clinical trial on behavioral relaxation approaches for insomnia in lung cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Insomnia | NA | Status: WITHDRAWN